Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-29

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Rizatriptan Benzoate by Macleods Pharmaceuticals Limited. The action adds regulatory approval for this generic migra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)